Status:
COMPLETED
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
Lead Sponsor:
University of Arizona
Conditions:
Actinic Keratoses
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This proposed project will be an open-label, split face, randomized controlled pilot study. Up to 60 patients with diffuse facial actinic keratosis will be enrolled in the study. The purpose of this s...
Detailed Description
The purpose of this study to understand the change in skin appearance during and after the course of 5-FU cream in patients with AK, and compare how the appearance of skin inflammation changes with th...
Eligibility Criteria
Inclusion
- Male and female, at least 18 years of age
- Subject must have a diagnosis of actinic keratosis (at least 5 lesions on each side of the face)
- Able to comprehend and read the English language
Exclusion
- Subjects who do not fit the inclusion criteria
- Concurrently have other inflammatory skin conditions.
- Prior known allergy to any components to of 5FU cream, topical steroid ointment or vaseline.
- • Subject who, in the opinion of the investigator, will be uncooperative or unable to comply with study procedures (i.e.: compliant with using 5-FU cream, topical corticosteroid or moisturizers
- Those that are prisoners or cognitively impaired.
Key Trial Info
Start Date :
October 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03279328
Start Date
October 10 2017
End Date
July 31 2018
Last Update
June 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona - Banner University Medicine Dermatology
Tucson, Arizona, United States, 85718